Picture of Clovis Oncology logo

CLVSQ — Clovis Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Clovis Oncology rises, top trending on Stocktwits

** Shares of Clovis Oncology  CLVS.O  rise 10.8% to $5.85
premarket
    ** Stock at a one-week high, set for its best day in nearly
four months if current levels hold 
    ** Stock top trending on online trading forum Stocktwits;
sentiment appears to be largely bullish with comments
encouraging traders to hold
    ** Stock sees wild swings over past two days, also among the
10 most mentioned stocks on Stocktwits over the past 24 hours 
    ** Co appoints Ronit Simantov, former vice president of
oncology global medical affairs at Pfizer  PFE.N  to its board
on Tuesday  urn:newsml:reuters.com:*:nBw4dD1rQa
    ** CLVS up 10% YTD

 (Reporting by Ambar Warrick)
 ((Ambar.Warrick@thomsonreuters.com; +91-80-6182-2837;))

Recent news on Clovis Oncology

See all news